Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yawen L. Chiang"'
Autor:
John Nemunaitis, Barrie J. Carter, Douglas J. Jolly, Estuardo Aguilar-Cordova, Dale Ando, Juan Armendáriz-Borunda, Steve Scherer, Joseph C. Glorioso, Michelle Rives, Parris R. Burd, Fintan R. Steele, Daniel R. Henderson, E. Brian Butler, Gerald P. McKenny, Yawen L. Chiang, Laura K. Aguilar, Savio L. C. Woo
Publikováno v:
Molecular Therapy. 1:385-388
Autor:
Martha C. Bohn, Donita Crippens, Yawen L. Chiang, Leena Bardwaj, Jiang Qian, Qing Lin, Yung Nien Chang, Beverly L. Davidson, Timothy J Schallert, DL Choi-Lundberg
Publikováno v:
Experimental Neurology. 154:261-275
Previously, we observed that an adenoviral (Ad) vector encoding human glial cell line-derived neurotrophic factor (GDNF), injected near the rat substantia nigra (SN), protects SN dopaminergic (DA) neuronal soma from 6-hydroxydopamine (6-OHDA)-induced
Autor:
Carl M. Hay, Beverly L. Davidson, Qing Lin, Yawen L. Chiang, Yung Nien Chang, DL Choi-Lundberg, Martha C. Bohn, Hasan M. Mohajeri
Publikováno v:
Science. 275:838-841
Glial cell line-derived neurotrophic factor (GDNF) supports growth and survival of dopaminergic (DA) neurons. A replication-defective adenoviral (Ad) vector encoding human GDNF injected near the rat substantia nigra was found to protect DA neurons fr
Publikováno v:
Electronic Journal of Biotechnology, Volume: 13, Issue: 1, Pages: 1-2, Published: 15 JAN 2010
Electronic Journal of Biotechnology v.13 n.1 2010
SciELO Chile
CONICYT Chile
instacron:CONICYT
Electronic Journal of Biotechnology v.13 n.1 2010
SciELO Chile
CONICYT Chile
instacron:CONICYT
We have developed analytical methods to measure the biological functions of pVGI.1(VEGF2), a naked plasmid DNA product containing vascular endothelial growth factor 2 used in clinical trials for coronary artery diseases (CAD) and peripheral artery di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44f09cb0ae39ecaf3588bb66237b52a
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582010000100001&lng=en&tlng=en
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582010000100001&lng=en&tlng=en
Autor:
Douglas Golightly, David A. Stewart, Yung-Nien Chang, Carl M. Hay, Sandrina Phipps, Yawen L. Chiang, Jane Lin, Paul L. Hallenbeck
Publikováno v:
Human gene therapy. 10(10)
Transducing and distributing a vector throughout a tumor mass are presently insufficient for effective cancer gene therapy. To overcome these difficulties an adenoviral vector was designed that would replicate specifically in tumor cells. This tumor-
Autor:
Yawen L. Chiang, Michelle Linscott, Yung-Nien Chang, Patricia Ryan, Cheau-Yun Chen, Gerard J. McGarrity
Publikováno v:
Human gene therapy. 6(11)
Transfer of the herpes simplex virus type-1 thymidine kinase (HSV-tk) gene into tumor cells followed by ganciclovir (GCV) administration, will provide selective tumor cell killing. We studied the effect of herpes simplex virus thymidine kinase (HSV-t
Autor:
Shuyuan Zhang, Yawen L. Chiang, Hitoshi Kotani, Edward Otto, Gerard J. McGarrity, R. Michael Blaese, Perry Newton, W. French Anderson, L. H. Weaver
Publikováno v:
Human gene therapy. 5(1)
To facilitate clinical applications of retroviral-mediated human gene transfer, retroviral vectors must be of high titer and free of detectable replication-competent retroviruses. The purpose of this study was to optimize methods of retroviral vector
Autor:
Yawen L. Chiang
Publisher Summary This chapter discusses the direct complementary DNA cloning and screening of mutants, using polymerase chain reaction. This chapter discusses the possibility of using the technique for direct complementary DNA (cDNA) cloning and for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bae9ca00d7b45759d6ba18194b40d5d
https://doi.org/10.1016/0076-6879(92)16010-h
https://doi.org/10.1016/0076-6879(92)16010-h
Publikováno v:
Molecular Therapy. 11:S359
Intramyocardial delivery of vascular endothelial growth factor-C (VEGF-2) has shown physiological and anatomic evidence of angiogenesis in animal models and clinical trials for myocardial ischemia. We evaluated safety and histopathological toxicity o
Publikováno v:
Molecular Therapy. 11:S220
The plasmid pVGI.1(VEGF2) contains 5283 base pairs and encodes the full length cDNA of the VEGF-2 gene. Preclinical studies and earlier clinical trials demonstrated that injecting the pVGI.1(VEGF2) directly into muscles provided therapeutic angiogeni